The ILC2 prevalence in postoperative blood was examined at an average of
6 months after ESS, and the postoperative LMK-CT score was examined at
an average of 14 months after ESS. The ILC2 prevalence in blood and the
LMK-CT score were significantly decreased after ESS in the eCRS and
non-eCRS patients (Figure 3A and B).
The ILC2 prevalence in postoperative blood was significantly decreased
in the good outcome group, but not in the poor outcome group (Figure 4).